These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 19603422

  • 1. PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells.
    Schild C, Wirth M, Reichert M, Schmid RM, Saur D, Schneider G.
    Mol Carcinog; 2009 Dec; 48(12):1149-58. PubMed ID: 19603422
    [Abstract] [Full Text] [Related]

  • 2. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.
    Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G.
    Cancer Res; 2007 May 01; 67(9):4149-56. PubMed ID: 17483325
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep 01; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 4. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP, Moraes MS, Rocha KM, Eichler CB, Hajj GN, Schwindt TT, Armelin HA.
    J Mol Endocrinol; 2004 Dec 01; 33(3):623-38. PubMed ID: 15591023
    [Abstract] [Full Text] [Related]

  • 5. Involvement of the tubulin tyrosine ligase-like family member 4 polyglutamylase in PELP1 polyglutamylation and chromatin remodeling in pancreatic cancer cells.
    Kashiwaya K, Nakagawa H, Hosokawa M, Mochizuki Y, Ueda K, Piao L, Chung S, Hamamoto R, Eguchi H, Ohigashi H, Ishikawa O, Janke C, Shinomura Y, Nakamura Y.
    Cancer Res; 2010 May 15; 70(10):4024-33. PubMed ID: 20442285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F, Löbke C, Ruschhaupt M, Cameron S, Schulten HJ, Schwager S, von Heydebreck A, Gunawan B, Langer C, Ramadori G, Sültmann H, Poustka A, Korf U, Füzesi L.
    J Pathol; 2008 Jul 15; 215(3):253-62. PubMed ID: 18438954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
    Zhang ML, Lu S, Zhou L, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2008 Oct 15; 7(5):533-8. PubMed ID: 18842503
    [Abstract] [Full Text] [Related]

  • 14. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW, Chang WH, Su YC, Chen YC, Lai YH, Wu PT, Hsu CI, Lin WC, Lai MK, Lin JY.
    Cancer Lett; 2009 Jan 08; 273(1):35-43. PubMed ID: 18809243
    [Abstract] [Full Text] [Related]

  • 15. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I, Silic-Benussi M, Rende F, Martines A, Fogar P, Basso D, Vella MD, Pedrazzoli S, Herman JG, Chieco-Bianchi L, Esposito G, Ciminale V, D'Agostino DM.
    Genes Chromosomes Cancer; 2009 May 08; 48(5):383-96. PubMed ID: 19170121
    [Abstract] [Full Text] [Related]

  • 16. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression.
    Wan C, Gong C, Zhang H, Hua L, Li X, Chen X, Chen Y, Ding X, He S, Cao W, Wang Y, Fan S, Xiao Y, Zhou G, Shen A.
    Cancer Lett; 2016 Apr 01; 373(1):67-76. PubMed ID: 26803058
    [Abstract] [Full Text] [Related]

  • 17. Loss of ONECUT1 expression in human pancreatic cancer cells.
    Jiang X, Zhang W, Kayed H, Zheng P, Giese NA, Friess H, Kleeff J.
    Oncol Rep; 2008 Jan 01; 19(1):157-63. PubMed ID: 18097590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M, Trinh E, Britschgi C, Britschgi A, Roh V, Vorburger SA, Tobler A, Leprince D, Fey MF, Helin K, Tschan MP.
    Mol Cancer Res; 2009 Jun 01; 7(6):916-22. PubMed ID: 19491197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.